Citi’s China brokerage push set to intensify competition in local market
Citigroup expects regulatory approval for its wholly-owned China brokerage business by September 2026, aiming to double staff to 100. This move intensifies competition with JPMorgan, Goldman Sachs, and Morgan Stanley in China's growing securities market. Citi plans to offer A-share brokerage, underwriting, and research services, leveraging its existing client base.
How this was made

The 30-second read
Why it matters
The approval would enable C to offer A‑share brokerage, underwriting, research and principal trading on‑shore, expanding its China franchise.
Market read
Citi's potential entry could reshape the competitive landscape of foreign banks in China's on‑shore securities market.
What to watch
China's tightening of foreign financial services rules could curb long‑term growth.
Background
Citi has been hiring for its China brokerage unit since 2021 and aims to double headcount to ~100 staff.
Ticker impact
Citi expects regulatory approval for its wholly‑owned China brokerage unit in September 2026.
Short‑term upside as investors price in approval probability.
Approval would allow C to compete with JPM, GS, MS in a fast‑growing market.
Market effects
Adds competitive pressure on other Wall Street banks in China brokerage space.
May increase foreign bank participation in Chinese A‑share brokerage.
Signals deeper US‑China financial integration despite geopolitical tensions.
Counterpoint
Regulatory risk remains high; approval could be delayed, limiting upside.
Key entities
- companyCitigroup
US‑based banking giant seeking China brokerage licence.
- companyJPMorgan
Competing Wall Street bank with existing China brokerage operations.
- companyGoldman Sachs
Competing Wall Street bank with China brokerage operations.
- companyMorgan Stanley
Competing Wall Street bank with China brokerage operations.





